Myriad Genetics Inc (NASDAQ:MYGN)

During the Trading Day
34.85 +0.88 / +2.59%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
34.85 0.00 / 0.00%
 
Volume: 40.9K

Today’s Trading

Previous close33.97
Today’s open34.13
Day’s range33.81 - 34.97
Volume521,777
Average volume (3 months)805,426
Market cap$2.4B
Dividend yield--
Data as of 3:59pm ET, 07/07/2015

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-40.01%
Earnings growth (next 5 years)+13.17%
Revenue growth (last year)+26.92%
P/E ratio27.8
Price/Sales3.42
Price/Book3.47

Competitors

 Today’s
change
Today’s
% change
--COSMO Pharmaceutical...+1.20+0.75%
TSROTESARO Inc+1.49+2.63%
CXRXConcordia Healthcare...-4.05-5.53%
ALDRAlder Biopharmaceuti...-3.62-6.92%
Data as of 4:00pm ET, 07/07/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)$0.41
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers